[1]
|
Albini, A., Pennesi, G., Donatelli, F., Cammarota, R., Flora, S.D. and Noonan, D.M. (2010) Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention. National Library of Medicine, 102, 14-25. https://doi.org/10.1093/jnci/djp440
|
[2]
|
Florescu, M., Cinteza, M. and Vinereanu, D. (2013) Chemotherapy-Induced Cardiotoxicity. Medica: A Journal of Clinical Medicine, 8, 59-67.
|
[3]
|
Herrman, J. and Lerman, A. (2014) An Update on Cardio-Oncology. Trends in Cardiovascular Medicine, 7, 285-295. https://doi.org/10.1016/j.tcm.2014.07.003
|
[4]
|
Peng, J., Rushton, M., Brezden-Masley, C., Chiu, M.G., Graham, I. and Dent, S. (2019) An International Survey of Healthcare Providers’ Knowledge of Cardiac Complications of Cancer Treatments. Cardio-Oncology, 5, No. 12. https://doi.org/10.1186/s40959-019-0049-2
|
[5]
|
Lyon, A.R., Dent, S., Stanway, S., Earl, H., Brenden-Masley, C., Cohen-Solal, A., Tocchetti, C.G., Moslehi, J.D., Bergler-Klein, J., Khoo, V., Tan, L.L., Anker, M.S., Haehling, S.V., Maack, C., Pudil, R., Barac, A., Thavendiranathan, P., Ky, B., Neilan, T.G., Belenkov, Y., Rosen, S.D., Lakobishvili, Z., Sverdlov, A.L., Hajjar, L.A., Macedo, A.V.S., Manisty, C., Ciardiello, F., Farmakis, D., Boer, R.A., Suter, T.M., Skouri, H., Cardinale, D., Witteles, R.M., Fradley, M.G., Herrmann, J., Cornell, R.F., Wechelaker, A., Mauro, M.J., Milojkovic, D., Lavallade, H., Ruschitzka, F., Coats, A.J.S., Seferovic, P.M., Chioncel, O., Thum, T., Bauersachs, J., Andres, M.S., Wright, D.J., Lopez-Fernandez, T., Plummer, C. and Lenihan, D. (2020) Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society. European Journal of Heart Failure, 11, 1945-1960. https://doi.org/10.1002/ejhf.1920
|
[6]
|
McGowan, J.V., Chung, R., Maulik, A., Piotrowska, I., Walker, J.M. and Yellon, D.M. (2017) Anthracycline Chemotherapy and Cardiotoxicity. Cardiovascular Drugs and Therapy, 31, 63-75. https://doi.org/10.1007/s10557-016-6711-0
|
[7]
|
Celutkine, J., Pudil, R., Lopez-Fernandez, T., Grapsa, J., Nihoyannopoulos, P., Bergler-Klein, J., Cohen-Solal, A., Farmakis, D., Tocchetti, C.G., Haehling, S.V., Barberis, V., Flachskampf, F.A., Ceponiene, I., Haegler-Laube, E., Suter, T., Lapinskas, T., Prasad, S., Boer, R.A., Wechalekar, K., Anker, M.S., Lakobishvili, Z., Bucciarelli-Ducci, C., Schulz-Menger, J., Cosyns, B., Gaemperli, O., Belenkov, Y., Hulot, J.-S., Galderisi, M., Lancellotti, P., Bax, J., Marwick, T.H., Chioncel, O., Jaarsma, T., Mullens, W., Piepoli, M., Thum, T., Heymans, S., Mueller, C., Moura, B., Ruschitzka, F., Zamorano, J.L., Rosano, G., Coats, A.J.S., Asteggiano, R., Seferovic, P., Edvardsen, T. and Lyon, A.R. (2020) Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European. European Journal of Heart Failure, 22, 1504-1524. https://doi.org/10.1002/ejhf.1957
|
[8]
|
Narayan, H.K., Finkelman, B., French, B., Plappert, T., Hyman, D., Smith, A.M., Margulies, K.B. and Ky, B. (2017) Detailed Echocardiographic Phenotyping in Breast Cancer Patients: Associations with Ejection Fraction Decline, Recovery, and Heart Failure Symptoms over 3 Years of Follow-Up. Circulation, 135, 1397-1412. https://doi.org/10.1161/CIRCULATIONAHA.116.023463
|
[9]
|
Zamorano, J.L., Lancellotti, P., Munoz, D.R., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D.J., Lip, G.Y.H., Lyon, A.R., Lopez Fernandez, T., Mohty, D., Piepoli, M.F., Tamargo, J., Torbicki, A. and Suter, T.M. (2016) 2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed under the Auspices of the ESC Committee for Practice Guidelines: The Task Force for Cancer Treatments and Cardiovascular Toxicity of the European Society of Cardiology (ESC). European Heart Journal, 37, 2768-2801. https://doi.org/10.1093/eurheartj/ehw211
|
[10]
|
Plana, J.C., Galderisi, M., Barac, A., Ewer, M.S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I.A., Agler, D.A., Badano, L.P., Banchs, J., Cardinale, D., Carver, J., Cerqueira, M., DeCara, J.M., Edvardsen, T., Flamm, S.D., Force, T., Griffin, B.P., Jerusalem, G., Liu, J.E., Magalhaes, A., Marwick, T., Sanchez, L.Y., Sicari, R., Villarraga, H.R. and Lancellotti, P. (2014) Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography, 27, 911-939. https://doi.org/10.1016/j.echo.2014.07.012
|
[11]
|
Mohebbi, E., Nahvijou, A., Hadji, M., Rashidian, H., Seyyedsalehi, M.S., Nemati, S., Rouhollahi, M.R. and Zendehdel, K. (2018) Iran Cancer Statistics in 2012 and Projection of Cancer Incidence by 2035. Basic & Clinical Cancer Research, 9, 3-22.
|
[12]
|
Murthy, N.S., Juneja, A., Sehgal, A., Prabhakar, A.K. and Luthra, U.K. (1990) Cancer Projection by the Turn of Century-Indian Science. Indian J Cancer, 27, 74-82.
|
[13]
|
Alizadehasl, A., Amin, A., Maleki, M., Noohi, F., Ghavamzadeh, A. and Farrashi, M. (2020) Cardio-Oncology Discipline: Focus on the Necessities in Developing Countries. ESC Heart Failure, 7, 2175-2183. https://doi.org/10.1002/ehf2.12838
|
[14]
|
Goldie, S.J., Gaffikin, L., Goldhaber-Fiebert, J.D., Gordilli-Tobar, A., Levin, C., Mahe, C. and Wright, T.C. (2005) Cost-Effectiveness of Cervical-Cancer Screening in Five Developing Countries. The New England Journal of Medicine, 53, 2158-2168. https://doi.org/10.1056/NEJMsa044278
|
[15]
|
Lima Lopes Jr, G., Souza, J.A. and Barrios, C. (2013) Access to Cancer Medications in Low-and Middle-Income Countries. Nature Reviews Clinical Oncology, 10, 314-322. https://doi.org/10.1038/nrclinonc.2013.55
|
[16]
|
Brar, S.S., Hong, N.L. and Wright, F.C. (2014) Multidisciplinary Cancer Care: Does it Improve Outcomes? Journal of Surgical Oncology, 110, 494-499. https://doi.org/10.1002/jso.23700
|
[17]
|
Lehmann, L.H. and Totzeck, M. (2020) Establishing an Oncocardiology Service. Herz, 45, 626-631. https://doi.org/10.1007/s00059-020-04952-w
|
[18]
|
Dreyfuss, A.D., Bravo, P.E., Koumenis, C. and Ky, B. (2019) Precision Cardio-Oncology. The Journal of Nuclear Medicine, 60, 443-450. https://doi.org/10.2967/jnumed.118.220137
|